Table 1

Mean percentage of patients achieving PASI 75 response with psoriasis biologic treatments
Agent Mean (%) 95% CI
Adalimumab 58 49–68
Etanercept 52 45–59
Infliximab 80 70–87
Ustekinumab 69 62–75

aThe relevant dosing scheme for each product is presented in Table 3.

CI, confidence interval; PASI, Psoriasis Area and Severity Index.

Source: Reich et al., 2012.

Avgerinou et al.

Avgerinou et al. BMC Dermatology 2012 12:10   doi:10.1186/1471-5945-12-10

Open Data